DCM
ABCL icon

Driehaus Capital Management’s AbCellera Biologics ABCL Stock Holding History

Driehaus Capital Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Sell
2,864,729
-1,160,050
-29% -$5.67M 0.13% 215
2026
Q1 		$14M Buy
4,024,779
+252,780
+7% +$910K 0.1% 247
2025
Q4 		$12.9M Buy
3,771,999
+2,045,058
+118% +$9.13M 0.09% 262
2025
Q3 		$8.69M Buy
1,726,941
+1,227,019
+245% +$5.41M 0.06% 290
2025
Q2 		$1.71M Buy
+499,922
New +$1.24M 0.01% 338

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Driehaus Capital Management's ABCL Position: Q2 2026 in Review

Driehaus Capital Management reduced its AbCellera Biologics (ABCL) stake by 29% in Q2 2026, selling an estimated $5.67M and leaving 2,864,729 shares worth $22.5M. The position accounts for 0.13% of the portfolio, ranked #215.

Driehaus Capital Management first reported a position in ABCL in Q2 2025 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Driehaus Capital Management held 2,864,729 shares of AbCellera Biologics worth $22.5M as of Q2 2026.
  • Driehaus Capital Management sold 1,160,050 AbCellera Biologics shares in Q2 2026, an estimated $5.67M.
  • AbCellera Biologics made up 0.13% of Driehaus Capital Management's portfolio in Q2 2026, its #215 holding.
  • Driehaus Capital Management first reported a position in AbCellera Biologics in Q2 2025 and has held it in 5 quarters since.
  • 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.